Literature DB >> 32042641

New metabolic tracers for detectable PSA levels in the post-prostatectomy setting: is the era of melting glaciers upcoming?

Rosario Mazzola1, Francesco Cuccia1, Vanessa Figlia1, Niccolò Giaj-Levra1, Luca Nicosia1, Francesco Ricchetti1, Michele Rigo1, Nadia Pasinetti2, Matteo Salgarello3, Filippo Alongi1,4.   

Abstract

Entities:  

Year:  2019        PMID： 32042641      PMCID： PMC6989844          DOI： 10.21037/tau.2019.12.34

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  22 in total

1.  Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study.

Authors:  Luca Triggiani; Rosario Mazzola; Stefano Maria Magrini; Gianluca Ingrosso; Paolo Borghetti; Fabio Trippa; Andrea Lancia; Beatrice Detti; Giulio Francolini; Fabio Matrone; Roberto Bortolus; Giuseppe Fanetti; Ernesto Maranzano; Francesco Pasqualetti; Fabiola Paiar; Marco Lorenzo Bonù; Alessandro Magli; Alessio Bruni; Ercole Mazzeo; Ciro Franzese; Marta Scorsetti; Filippo Alongi; Barbara Alicja Jereczek-Fossa; Piet Ost; Michela Buglione
Journal:  World J Urol       Date:  2019-03-11       Impact factor: 4.226

2.  A Systematic Review on the Role of Imaging in Early Recurrent Prostate Cancer.

Authors:  Pieter J L De Visschere; Chloë Standaert; Jurgen J Fütterer; Geert M Villeirs; Valeria Panebianco; Jochen Walz; Tobias Maurer; Boris A Hadaschik; Frédéric E Lecouvet; Gianluca Giannarini; Stefano Fanti
Journal:  Eur Urol Oncol       Date:  2018-10-24

3.  (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.

Authors:  Pim J van Leeuwen; Phillip Stricker; George Hruby; Andrew Kneebone; Francis Ting; Ben Thompson; Quoc Nguyen; Bao Ho; Louise Emmett
Journal:  BJU Int       Date:  2016-01-24       Impact factor: 5.588

4.  Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity.

Authors:  Sergio Fersino; Umberto Tebano; Rosario Mazzola; Niccolò Giaj-Levra; Francesco Ricchetti; Gioacchino Di Paola; Alba Fiorentino; Gianluisa Sicignano; Stefania Naccarato; Ruggero Ruggieri; Stefano Cavalleri; Filippo Alongi
Journal:  Clin Genitourin Cancer       Date:  2017-02-06       Impact factor: 2.872

5.  Impact of 18F-Choline PET/CT in the Decision-Making Strategy of Treatment Volumes in Definitive Prostate Cancer Volumetric Modulated Radiation Therapy.

Authors:  Filippo Alongi; Sergio Fersino; Niccolò Giaj Levra; Rosario Mazzola; Francesco Ricchetti; Alba Fiorentino; Ruggero Ruggieri; Veronica Malfatti; Stefano Cavalleri; Matteo Salgarello
Journal:  Clin Nucl Med       Date:  2015-11       Impact factor: 7.794

6.  Extent of disease in recurrent prostate cancer determined by [(68)Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score.

Authors:  Frederik A Verburg; David Pfister; Axel Heidenreich; Andreas Vogg; Natascha I Drude; Stefan Vöö; Felix M Mottaghy; Florian F Behrendt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-12       Impact factor: 9.236

7.  Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.

Authors:  Piet Ost; Dries Reynders; Karel Decaestecker; Valérie Fonteyne; Nicolaas Lumen; Aurélie De Bruycker; Bieke Lambert; Louke Delrue; Renée Bultijnck; Tom Claeys; Els Goetghebeur; Geert Villeirs; Kathia De Man; Filip Ameye; Ignace Billiet; Steven Joniau; Friedl Vanhaverbeke; Gert De Meerleer
Journal:  J Clin Oncol       Date:  2017-12-14       Impact factor: 44.544

8.  Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis.

Authors:  Luca Nicosia; Ciro Franzese; Rosario Mazzola; Davide Franceschini; Michele Rigo; Giuseppe D'agostino; Stefanie Corradini; Filippo Alongi; Marta Scorsetti
Journal:  Strahlenther Onkol       Date:  2019-09-26       Impact factor: 3.621

9.  A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).

Authors:  Noura Radwan; Ryan Phillips; Ashley Ross; Steven P Rowe; Michael A Gorin; Emmanuel S Antonarakis; Curtiland Deville; Stephen Greco; Samuel Denmeade; Channing Paller; Daniel Y Song; Maximilian Diehn; Hao Wang; Michael Carducci; Kenneth J Pienta; Martin G Pomper; Theodore L DeWeese; Adam Dicker; Mario Eisenberger; Phuoc T Tran
Journal:  BMC Cancer       Date:  2017-06-29       Impact factor: 4.430

Review 10.  Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.

Authors:  Henk B Luiting; Pim J van Leeuwen; Martijn B Busstra; Tessa Brabander; Henk G van der Poel; Maarten L Donswijk; André N Vis; Louise Emmett; Phillip D Stricker; Monique J Roobol
Journal:  BJU Int       Date:  2019-11-29       Impact factor: 5.588
View more
  12 in total

1.  Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomes.

Authors:  Rosario Mazzola; Francesco Cuccia; Vanessa Figlia; Michele Rigo; Luca Nicosia; Niccolò Giaj-Levra; Francesco Ricchetti; Claudio Vitale; Beatrice Mantoan; Gioacchino Di Paola; Antonio De Simone; Davide Gurrera; Gianluisa Sicignano; Stefania Naccarato; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiol Med       Date:  2021-04-09       Impact factor: 3.469

2.  Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting.

Authors:  Giulio Francolini; Giulia Stocchi; Beatrice Detti; Vanessa Di Cataldo; Alessio Bruni; Luca Triggiani; Andrea Emanuele Guerini; Rosario Mazzola; Francesco Cuccia; Matteo Mariotti; Viola Salvestrini; Pietro Garlatti; Simona Borghesi; Gianluca Ingrosso; Rita Bellavita; Cynthia Aristei; Isacco Desideri; Lorenzo Livi
Journal:  Radiol Med       Date:  2021-11-30       Impact factor: 3.469

3.  Postoperative moderately hypofractionated radiotherapy in prostate cancer: a mono-institutional propensity-score-matching analysis between adjuvant and early-salvage radiotherapy.

Authors:  Luca Nicosia; Rosario Mazzola; Claudio Vitale; Francesco Cuccia; Vanessa Figlia; Niccolò Giaj-Levra; Francesco Ricchetti; Michele Rigo; Ruggiero Ruggeri; Stefano Cavalleri; Filippo Alongi
Journal:  Radiol Med       Date:  2022-03-26       Impact factor: 3.469

4.  Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer.

Authors:  Francesco Cuccia; Luca Nicosia; Rosario Mazzola; Vanessa Figlia; Niccolò Giaj-Levra; Francesco Ricchetti; Michele Rigo; Claudio Vitale; Stefanie Corradini; Ruggero Ruggieri; Filippo Alongi
Journal:  Strahlenther Onkol       Date:  2020-05-12       Impact factor: 3.621

5.  Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance.

Authors:  Luca Triggiani; Rosario Mazzola; Davide Tomasini; Alessio Bruni; Giulia Alicino; Fabio Matrone; Roberto Bortolus; Giulio Francolini; Beatrice Detti; Alessandro Magli; Marco Lorenzo Bonù; Gianluca Ingrosso; Andrea Lancia; Fabio Trippa; Ernesto Maranzano; Ciro Franzese; Paolo Ghirardelli; Vittorio Vavassori; Marta Scorsetti; Filippo Alongi; Stefano Maria Magrini
Journal:  Med Oncol       Date:  2021-05-18       Impact factor: 3.064

6.  External beam radiotherapy for prostate cancer: What are the current research trends and hotspots?

Authors:  Rui Li; Xia Liu; Bo Yang; Jie Qiu
Journal:  Cancer Med       Date:  2021-01-21       Impact factor: 4.452

7.  Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience.

Authors:  Jure Murgic; Blanka Jaksic; Marin Prpic; Davor Kust; Amit Bahl; Mirjana Budanec; Angela Prgomet Secan; Pierfrancesco Franco; Ivan Kruljac; Borislav Spajic; Nenad Babic; Bozo Kruslin; Mario Zovak; Eduardo Zubizarreta; Eduardo Rosenblatt; Ana Fröbe
Journal:  Radiat Oncol       Date:  2021-05-12       Impact factor: 3.481

8.  Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT.

Authors:  Vasileios Karagiannis; Viktor Wichmann; Juha Saarinen; Natalja Eigeliene; Heidi Andersen; Antti Jekunen
Journal:  Radiat Oncol       Date:  2022-01-29       Impact factor: 3.481

9.  Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer.

Authors:  Paul Rogowski; Christian Trapp; Rieke von Bestenbostel; Nina-Sophie Schmidt-Hegemann; Run Shi; Harun Ilhan; Alexander Kretschmer; Christian Stief; Ute Ganswindt; Claus Belka; Minglun Li
Journal:  Radiat Oncol       Date:  2021-06-30       Impact factor: 3.481

10.  Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes.

Authors:  Ron Lewin; Uri Amit; Menachem Laufer; Raanan Berger; Zohar Dotan; Liran Domachevsky; Tima Davidson; Orith Portnoy; Lev Tsvang; Maoz Ben-Ayun; Ilana Weiss; Zvi Symon
Journal:  Radiat Oncol       Date:  2021-06-23       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.